- 2024-08-20 02:18抑制剂Wnt/β-catenin agonist 3|Wnt/β-catenin agonist 3|912790-59-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂WH-4-025|WH-4-025|1876463-35-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂WJ460|WJ460|1415251-36-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:18抑制剂WJ460|WJ460|1415251-36-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂WAY-661012|WAY-661012|872319-20-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂WAY-661012|WAY-661012|872319-20-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂WH-4-025|WH-4-025|1876463-35-2|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:18抑制剂WH-4-025|WH-4-025|1876463-35-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂WAY-100635 Maleate|WAY-100635 Maleate|1092679-51-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂WAY-100635 Maleate|WAY-100635 Maleate|1092679-51-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂WAY-661012|WAY-661012|872319-20-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:18抑制剂W-84 dibromide|W-84 dibromide|21093-51-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂W-84 dibromide|W-84 dibromide|21093-51-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂WAY-100635 Maleate|WAY-100635 Maleate|1092679-51-0|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:18抑制剂W36017|W36017|21236-54-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂W36017|W36017|21236-54-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂W-84 dibromide|W-84 dibromide|21093-51-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:18抑制剂W36017|W36017|21236-54-4|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:18抑制剂VY-3-135|VY-3-135|1824637-41-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:18抑制剂VY-3-135|VY-3-135|1824637-41-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
